lithium has been researched along with selegiline in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schneider, LS; Sobin, PB | 1 |
Nag, M; Nandi, N | 1 |
Lang, AE | 1 |
Zaleska, B | 1 |
Mitchell, PB | 1 |
Fann, JR | 1 |
4 review(s) available for lithium and selegiline
Article | Year |
---|---|
Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia.
Topics: Adrenergic beta-Antagonists; Alzheimer Disease; Buspirone; Carbamazepine; Dementia; Humans; Lithium; Neurotransmitter Uptake Inhibitors; Selegiline; Serotonin; Trazodone | 1992 |
[Progress in the treatment of degenerative diseases of the nervous system. Selected problems].
Topics: Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Humans; Huntington Disease; Lithium; Neostigmine; Parkinson Disease; Penicillamine; Phthalazines; Selegiline; Tetrabenazine; Tiapamil Hydrochloride | 1980 |
Drug interactions of clinical significance with selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoenzymes; Lithium; Liver; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Selegiline; Sumatriptan; Tryptophan | 1997 |
Neurological effects of psychopharmacological agents.
Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Bundle-Branch Block; Delirium; Depressive Disorder; Humans; Lithium; Male; Nervous System Diseases; Parkinson Disease; Psychotropic Drugs; Selegiline | 2002 |
2 other study(ies) available for lithium and selegiline
Article | Year |
---|---|
Antidepressants and brain respiration.
Topics: Amphetamine; Animals; Antidepressive Agents; Brain; Chlorides; Chlorpromazine; Clorgyline; Glucose; Imipramine; Lithium; Lithium Chloride; Male; Oxygen Consumption; Rats; Selegiline; Tranylcypromine | 1991 |
Treatment of Parkinson's disease with agents other than levodopa and dopamine agonists: controversies and new approaches.
Topics: Adrenergic beta-Antagonists; Amantadine; Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Dopamine; Dopamine Antagonists; Humans; Lithium; Neurology; Parasympatholytics; Parasympathomimetics; Parkinson Disease; Selegiline; Serotonin; Sympathomimetics | 1984 |